AdaptivCRT Algorithm Put To The Test In Medtronic’s Superiority Trial
This article was originally published in The Gray Sheet
Executive Summary
The first of a planned 3,000 patients have been enrolled in the AdaptResonse trial of Medtronic’s AdaptivCRT cardiac resynchronization algorithm. Previous studies have shown the algorithm reduces hospitalizations, and Medtronic hopes AdaptResponse will show it reduces mortality and medical interventions.